Overexpression of the IGFBP5 mediator of insulin-like growth factor receptor (IGF1R) signalling inhibits the transformation of human melanoma cells in culture whilst TNS1 expression is down-regulated in multiple cancers including melanoma [34, 35]. This evidence concerns the gene IGF1R and cancer.